| Original language | Korean |
|---|---|
| Journal | LANCET ONCOLOGY |
| State | Published - 2020.08.1 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial
Research output: Contribution to journal › Journal article › peer-review